Yep MHT could be all that we are hoping. But my interest in this business is that it looked like the stock was worth near a dollar on the blood culture products, and MHT's success would be cream.
Structurally the business is in a strong position with debt paid down and reducing the share register. However I think the intrinsic value of the business is reduced on the back of this forecast.
